Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Inovio Soars as Reddit Crowd Takes Notice, BlackRock Boosts Stake
By Rob Lenihan
Feb 2, 2021 9:06 AM EST
PRESS RELEASES
BioCryst To Report First Quarter 2021 Financial Results On May 6
By GlobeNewswire
Apr 22, 2021 7:00 AM EDT
PRESS RELEASES
BioCryst Announces Approval Of Japanese NHI Price Listing Of ORLADEYO™ (berotralstat) For Prophylactic Treatment Of Hereditary Angioedema
By GlobeNewswire
Apr 14, 2021 8:15 AM EDT
PRESS RELEASES
BioCryst To Present At 20th Annual Needham Virtual Healthcare Conference
By GlobeNewswire
Apr 7, 2021 7:00 AM EDT
PRESS RELEASES
BioCryst's Oral Factor D Inhibitor, BCX9930, Advancing To Pivotal Trials In PNH Following Successful Proof Of Concept Trial
By GlobeNewswire
Mar 22, 2021 8:00 AM EDT
PRESS RELEASES
BioCryst Appoints Helen Thackray, M.D., As Chief Research And Development Officer
By GlobeNewswire
Mar 19, 2021 7:00 AM EDT
PRESS RELEASES
BioCryst To Host Virtual R&D Day On March 22, 2021
By GlobeNewswire
Mar 15, 2021 7:00 AM EDT
PRESS RELEASES
Early Access To BioCryst's Berotralstat Granted For HAE Patients In France
By GlobeNewswire
Mar 11, 2021 8:30 AM EST
PRESS RELEASES
BioCryst Submits Marketing Authorization Application For UK Approval Of ORLADEYO™ (berotralstat), An Oral, Once-daily Therapy To Prevent Attacks In Patients With Hereditary Angioedema
By GlobeNewswire
Mar 2, 2021 7:00 AM EST
PRESS RELEASES
BioCryst Receives Positive CHMP Opinion For ORLADEYO™ (berotralstat), An Oral, Once-daily Therapy To Prevent Attacks In Patients With Hereditary Angioedema
By GlobeNewswire
Feb 25, 2021 4:15 PM EST
PRESS RELEASES
BioCryst To Present At Upcoming Investor Conferences
By GlobeNewswire
Feb 18, 2021 7:00 AM EST
PRESS RELEASES
BioCryst To Report Fourth Quarter And Full Year 2020 Financial Results On February 25
By GlobeNewswire
Feb 11, 2021 7:00 AM EST
PRESS RELEASES
BioCryst To Present Data At 2021 American Academy Of Allergy, Asthma & Immunology Annual Meeting
By GlobeNewswire
Feb 9, 2021 7:15 AM EST
PRESS RELEASES
BioCryst Announces FDA Approval Of Supplemental New Drug Application For RAPIVAB® Expanding Patient Population To Include Children Six Months And Older
By GlobeNewswire
Feb 3, 2021 7:00 AM EST
INVESTING
Inovio Soars as Reddit Crowd Takes Notice, BlackRock Boosts Stake
By Rob Lenihan
Feb 2, 2021 9:06 AM EST
PRESS RELEASES
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Feb 2, 2021 7:00 AM EST
JIM CRAMER
Accentuate the Positive: Cramer's 'Mad Money' Recap (Monday 1/11/21)
By Scott Rutt
Jan 11, 2021 8:27 PM EST
PRESS RELEASES
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Jan 7, 2021 7:00 AM EST
PRESS RELEASES
BioCryst To Present At 39th Annual J.P. Morgan Healthcare Conference
By GlobeNewswire
Jan 6, 2021 7:00 AM EST
PRESS RELEASES
BioCryst Provides Update On Galidesivir Program
By GlobeNewswire
Dec 22, 2020 7:00 AM EST
PRESS RELEASES
BioCryst To Present At JMP Securities Hematology Summit
By GlobeNewswire
Dec 11, 2020 7:00 AM EST
PRESS RELEASES
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Dec 1, 2020 4:15 PM EST
PRESS RELEASES
BioCryst To Present At Upcoming Virtual Investment Conferences
By GlobeNewswire
Nov 20, 2020 7:00 AM EST
PRESS RELEASES
BioCryst Presents Data Showing Sustained Attack Rate Reductions, Improved Patient Satisfaction And Quality Of Life For HAE Patients Taking Berotralstat In APeX-2 Trial
By GlobeNewswire
Nov 13, 2020 7:02 AM EST
PRESS RELEASES
BioCryst Presents New Data Highlighting Burden Of Therapy With Current Injectable Prophylaxis Medication For HAE
By GlobeNewswire
Nov 13, 2020 7:00 AM EST
